SMAD2 and chronic kidney disease: Thus, changes in the expression of TGF-β1, Smad2/Smad3, αSMA, COL1A1, collagen, and fibronectin in the CKD model reflect excessive ECM accumulation and continuous fibrosis progression, which ultimately lead to structural changes in the renal tissues and functional decline (Eddy, 2005).